Literature DB >> 26184746

The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.

Federico Cacciapuoti1.   

Abstract

INTRODUCTION: The diagnosis of cardiac amyloidosis (CA) is usually performed by endomyocardial biopsy; however, possible sampling errors and procedural risks such as cardiac tamponade, malignant arrhythmias and bleeding risk, limit its use. Therefore, a non-invasive diagnostic method appears to be necessary.
MATERIALS AND METHODS: Echocardiography plays an important role in this need. Conventional two-dimensional echocardiography appears able to detect some specific and distinguishing signs of cardiac amyloid infiltration. RESULTS AND
CONCLUSIONS: Of these, thickened right and left ventricular (LV) myocardium, normal or small LV cavity size in contrast to enlarged biatrial cavities, diffuse hyper-refractile 'granular sparkling' appearance and 'mismatch' ECG/ECHO are the most specific findings. The magnitude of cyclic variation recorded with integrated backscatter reflects structural changes in the myocardium. In patients with CA, this magnitude is reduced because myocardial amyloid infiltration is characterized by a reduction of number of "contractile" fibers. Other informations concerning LV dysfunction CA-related can be obtained by Tei index. Finally, new echocardiographic imaging modalities, such as tissue Doppler, Doppler-based strain, speckle tracking imaging and three-dimensional echocardiography, can provide some findings regarding the preclinical stages of LV dysfunction when other echocardiographic measurements are showing normal; however, these are unable to provide a non-invasive diagnosis of cardiac amyloidosis.

Entities:  

Mesh:

Year:  2015        PMID: 26184746     DOI: 10.1007/s12574-015-0249-1

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  30 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

Review 4.  Ultrasonic characterization of myocardium.

Authors:  J G Miller; J E Pérez; B E Sobel
Journal:  Prog Cardiovasc Dis       Date:  1985 Sep-Oct       Impact factor: 8.194

5.  Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis.

Authors:  S W Dubrey; K Cha; R W Simms; M Skinner; R H Falk
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

Review 6.  Amyloidosis and the heart: a comprehensive review.

Authors:  Keyur B Shah; Yoshio Inoue; Mandeep R Mehra
Journal:  Arch Intern Med       Date:  2006-09-25

7.  Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.

Authors:  Takashi Oki; Hideji Tanaka; Hirotsugu Yamada; Tomotsugu Tabata; Yoshifumi Oishi; Takeo Ishimoto; Norio Nagase; Hisanori Shinohara; Koichi Sakabe; Nobuo Fukuda
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

8.  Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

Authors:  A L Klein; L K Hatle; D J Burstow; J B Seward; R A Kyle; K R Bailey; T F Luscher; M A Gertz; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.

Authors:  Takeshi Hattori; Yo-ichi Takei; Jun Koyama; Masamitsu Nakazato; Shu-ichi Ikeda
Journal:  Amyloid       Date:  2003-12       Impact factor: 7.141

Review 10.  The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Authors:  G Merlini; P Westermark
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

View more
  14 in total

Review 1.  Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.

Authors:  Dalia Di Nunzio; Antonino Recupero; Cesare de Gregorio; Concetta Zito; Scipione Carerj; Gianluca Di Bella
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 2.931

Review 2.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 3.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

4.  Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis.

Authors:  Muzammil Muhammad Khan; Mamoon Ur Rashid; Waqas Ullah; Ishtiaq Hussain; Abu Hurairah
Journal:  BMJ Case Rep       Date:  2020-01-28

Review 5.  Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.

Authors:  Vasiliki Bistola; John Parissis; Emmanouil Foukarakis; Pipitsa N Valsamaki; Aris Anastasakis; Georgios Koutsis; Georgios Efthimiadis; Efstathios Kastritis
Journal:  Heart Fail Rev       Date:  2021-01-15       Impact factor: 4.214

Review 6.  Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.

Authors:  M Hasib Sidiqi; Morie A Gertz
Journal:  Blood Cancer J       Date:  2021-05-15       Impact factor: 11.037

Review 7.  Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.

Authors:  Morie A Gertz
Journal:  Blood Cancer J       Date:  2018-05-23       Impact factor: 11.037

8.  Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Authors:  Panagiota Kyriakou; Dimitrios Mouselimis; Anastasios Tsarouchas; Angelos Rigopoulos; Constantinos Bakogiannis; Michel Noutsias; Vasileios Vassilikos
Journal:  BMC Cardiovasc Disord       Date:  2018-12-04       Impact factor: 2.298

Review 9.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

10.  Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese.

Authors:  Hui-Ching Hsu; Ming-Feng Liao; Jung-Lung Hsu; Ai-Lun Lo; Hung-Chou Kuo; Rong-Kuo Lyu; Victor Chien-Chia Wu; Chih-Wei Wang; Long-Sun Ro
Journal:  BMC Neurol       Date:  2017-09-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.